DAS181 and H5N1 virus infection

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1250-

  Zhang, Hong ^a,b  

^a Z BioMed   (United States)

^b 15725 Crabbs Branch Way ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PROTEIN DAS181; UNCLASSIFIED DRUG;

AVIAN INFLUENZA; INFLUENZA VIRUS A H5N1; LETTER; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

ANIMALS; ANTIVIRAL AGENTS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT FUSION PROTEINS;

EID: 65649127744     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597479     Document Type: Letter

References (2)

1. Belser JA, Lu X, Szretter KJ, et al.DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007; 196:1493-9.
2. Ilyushina NA, Hoffmann E, Solomon R, Webster RG, Govorkova EA. Amantadineoseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir Ther 2007; 12:363-70.